-
Financial reporting by US companies will undergo unprecedented change over the next several years. International Financial Reporting ...
-
|
|
Analysis & opinions on global M&A activity from our network of local advisers 2006/2007
|
(English)
|
Welcome to the latest edition of M&A Insights, an annual review of deal activity and key trends within the pharmaceutical and ...
-
|
|
IFRS Revenue Recognition Guidance
|
(English)
|
Pay-For-Performance is a pricing concept under which the price paid for a given medicine is intended to reflect the economic benefits ...
-
|
|
Which path will you take?
|
(English)
|
-
|
|
Are you readjusting your sights?
|
(English)
|
The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need ...
